Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats.
Ceprián M, Vargas C, García-Toscano L, Penna F, Jiménez-Sánchez L, Achicallende S, Elezgarai I, Grandes P, Hind W, Pazos MR, Martínez-Orgado J. Ceprián M, et al. Among authors: garcia toscano l. Front Pharmacol. 2019 Sep 26;10:1131. doi: 10.3389/fphar.2019.01131. eCollection 2019. Front Pharmacol. 2019. PMID: 31611802 Free PMC article.
Structure-Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives.
Götz MR, Collado JA, Fernández-Ruiz J, Fiebich BL, García-Toscano L, Gómez-Cañas M, Koch O, Leha A, Muñoz E, Navarrete C, Pazos MR, Holzgrabe U. Götz MR, et al. Among authors: garcia toscano l. Front Pharmacol. 2019 Nov 20;10:1284. doi: 10.3389/fphar.2019.01284. eCollection 2019. Front Pharmacol. 2019. PMID: 31824305 Free PMC article.
Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].
Gómez-Cañas M, Morales P, García-Toscano L, Navarrete C, Muñoz E, Jagerovic N, Fernández-Ruiz J, García-Arencibia M, Pazos MR. Gómez-Cañas M, et al. Among authors: garcia toscano l. Pharmacol Res. 2017 Jun;120:302. doi: 10.1016/j.phrs.2017.04.002. Epub 2017 Apr 20. Pharmacol Res. 2017. PMID: 28433484 No abstract available.
Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis.
Espejo-Porras F, García-Toscano L, Rodríguez-Cueto C, Santos-García I, de Lago E, Fernandez-Ruiz J. Espejo-Porras F, et al. Among authors: garcia toscano l. Br J Pharmacol. 2019 May;176(10):1585-1600. doi: 10.1111/bph.14216. Epub 2018 May 6. Br J Pharmacol. 2019. PMID: 29574689 Free PMC article.
Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis.
Rodríguez-Cueto C, Santos-García I, García-Toscano L, Espejo-Porras F, Bellido M, Fernández-Ruiz J, Muñoz E, de Lago E. Rodríguez-Cueto C, et al. Among authors: garcia toscano l. Biochem Pharmacol. 2018 Nov;157:217-226. doi: 10.1016/j.bcp.2018.07.049. Epub 2018 Aug 1. Biochem Pharmacol. 2018. PMID: 30076846
Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis.
Rodríguez-Cueto C, García-Toscano L, Santos-García I, Gómez-Almería M, Gonzalo-Consuegra C, Espejo-Porras F, Fernández-Ruiz J, de Lago E. Rodríguez-Cueto C, et al. Among authors: garcia toscano l. Br J Pharmacol. 2021 Mar;178(6):1373-1387. doi: 10.1111/bph.15386. Epub 2021 Feb 20. Br J Pharmacol. 2021. PMID: 33486755 Free article. Review.
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists.
Murineddu G, Deligia F, Ragusa G, García-Toscano L, Gómez-Cañas M, Asproni B, Satta V, Cichero E, Pazos R, Fossa P, Loriga G, Fernández-Ruiz J, Pinna GA. Murineddu G, et al. Among authors: garcia toscano l. Bioorg Med Chem. 2018 Jan 1;26(1):295-307. doi: 10.1016/j.bmc.2017.11.051. Epub 2017 Dec 2. Bioorg Med Chem. 2018. PMID: 29229226
11 results